In vitro and in vivo studies on the degradation of metallothionein. by Klaassen, C D et al.
In Vitroand In Vivo Studies on the Degradation
of Metallothionein
Curtis D. Klaassen, Supratim Choudhuri, James M. McKim, Jr.,
Lois D. Lehman-McKeeman, and William C. Kershaw
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center,
Kansas City, Kansas
Degradation of metallothionein (MT) from rat liver was examined. Degradation of apo-MT by liver homogenate was greater than that by cytosol. At
pH 5.5, degradation by homogenate was more than that at pH 7.2. These findings suggest that proteases that function at acidic pH are probably
involved in MT degradation. Because lysosomes are the principal subcellular organelles that contain acid proteases (cathepsins), we compared the
degradation of apo-MT by lysosomes and cytsosol. Apo-MT was degraded about 400 times faster by lysosomal fraction than by cytosolic fraction.
To determine the relative importance of different cathepsins, we used different inhibitors. Leupeptin, which inhibits cathepsins B and L, inhibited the
degradation of apo-MT by 80%, implying that cathepsins B and/or L might be very important in the intracellular turnover of MT. Cathepsin D
appeared to be the least significant, because apo-MT degradation was reduced by about 20% by inhibiting cathepsin D. When we extended this
study with purified cathepsins, we obtained the same answer, i.e., the ability of different cathepsins to degrade apo-MT was in the following order:
cathepsin B >> cathepsin C > cathepsin D. While apo-MT was susceptible to degradation, ZnMT and CdMT were highly resistant to degradation.
Coincubation of ZnMT or CdMT with either lysosomal extract or purified cathepsins did not result in any appreciable degradation even after 16 hr.
However, longer incubations did result in some degradation, especially by purified cathepsin B. Interestingly, CdMT degraded little faster than ZnMT
by both lysosomal extract as well as purified cathepsin B. These data suggest that metals protect MT from rapid proteolysis. By metal-titration
study, we found that at least 5 moles of Zn equivalent/mole of MT dramatically reduced the degradation, by both lysosomal fraction and purified
cathepsin B. This indicates that metal release might be a prerequisite forthe initiation of degradation. Release of metals is possible in the lysosomes
because the intralysosomal pH is close to 5.0. Therefore, we determined the displacement of metals (Zn) as a function of pH. We found that at a pH
of 4.5, nearly 70% Zn was removed, and at pH 4.0 nearly all Zn was displaced from MT. We propose, therefore, that lysosomes are probably impor-
tant in the in vivo degradation of MT, and that metal release is a prerequisite for degradation. With the release of metals in the acidic pH of lyso-
somes, MT becomes more susceptible to degradation, which is probably accomplished by the cathepsins, in particular cathepsin B and/or L. The in
vivo study, however, suggests that there are other factors, too, in addition to metal composition and pH, that may have profound effect on deter-
mining the half-lives of various forms of MT, at various stages of development. - Environ Health Perspect 102(Suppl 3):141-146 (1994).
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Introduction
Conditions that affect the synthesis of met-
allothionein (MT) provide important
information concerning its importance in
different tissues, and during various physi-
ological conditions. Equally important in
understanding the functions and regulation
of MT, but less well understood, is the
degradation of the protein and turnover of
the metals bound to it.
For the last several years, research in
our laboratory has focused on characteriz-
ing the degradation ofhepatic MT in a rat
model system. When we undertook the
studies, not much information was avail-
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able on the degradation of MT.
Nevertheless, a few studies were done ear-
lier on this aspect, and the information
emanating from them could be distilled
into the following concepts: lysosomes
might be important in degrading MT;
metals protect MT from rapid degradation;
the order ofsensitivity towards degradation
is apo-MT>>ZnMT>CdMT; and degrada-
tion of MT and metal release probably
occur concomitantly.
The principal objectives of our current
studies were to answer many other aspects
ofMT degradation that were not addressed
by the previous studies, viz., to identify the
subcellular site(s) in which the degradation
ofhepatic MT occurs; to identify the pro-
tease(s) most likely involved in the in vivo
turnover of MT; to determine the relative
efficiency of different proteases to degrade
MT; to quantitatively compare the degra-
dation ofapo-MT, ZnMT, and CdMT; to
evaluate the extent of protection provided
by the metals; and finally to obtain a more
thorough understanding ofthe biochemical
processes that regulate the degradation of
this important metal-binding protein.
Methods
Lysosomes were prepared by differential
centrifugation followed by a phase separa-
tion technique (1). Radiolabeled apo-MT
was prepared according to Sendelbach and
Klaassen (2) from livers of rats that
received subacute exposure to Cd or Zn,
and [35S]-cysteine. To prepare apo-MT,
metals were removed from the protein by
dialysis against 0.1 M HCI solution. We
obtained fully saturated ZnMT and CdMT
by titrating MT with the respective metals
(Zn or Cd) bound to it, followed by desalt-
ing to remove excess unbound metals
(3,4).
Proteolytic reactions were carried out
in vitro at pH 5.5 or 7.2, using 0.5 M
sodium acetate or 0.1 M sodium phosphate
buffer, respectively. Although the lysoso-
mal pH is close to 5.0 (5,6), we chose pH
5.5 because preliminary experiments in our
laboratory showed that, at this pH, all met-
als are retained by MT while the lysosomal
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acid proteases remain active. For most of
our experiments, we used MT-I. The opti-
mum ratio of apo-MT to homogenate or
cytosolic protein was determined to be 1:1
(50 pg apo-MT: 50 pg homogenate or
cytosolic protein). For ZnMT and CdMT
the same ratio was found to be optimum.
The optimum ratio of apo-MT to lysoso-
mal protein was 80:1 (50 pg apo-
MT :0.625 pg lysosomal protein).
Incubates with a final volume of 100 pl
were maintained at 370C. When apo-MT
was used as a substrate, the reactions were
sampled at 0, 0.5, 1.0, and 2.0 hr, after
introduction of all components to the
digestion mixture. When ZnMT or CdMT
were used as substrates, the reactions were
sampled at 0, 6, 12, and 16 hr. Samples
were rapidly placed in the denaturing
buffer to stop the reaction, flash-frozen in
liquid nitrogen, and stored at-80°C.
Samples of different time points were
then subjected to SDS-PAGE analysis as
described by Hames (7), and stained by
Coomassie brilliant blue. Prior to elec-
trophoresis, the samples were car-
boxymethylated according to Otsuka et al.
(8), with slight modification. The unde-
graded MT bands were excised from the
gel, solubilized, mixed with scintillation
cocktail, and analyzed for radioactivity
using ascintillation spectrometer.
MT degradation was quantified by
measuring the disappearance of the unde-
graded parent bands. The reduction ofcpm
values in the undegraded parent bands of
each time point, compared to the 0 hr time
point band, was used as the index of MT
degradation. Based on prior determinations
ofthe specific activitiy ofour MT prepara-
tions (cpm/pg protein), the cpm values
were converted to the amount of protein.
The values thus obtained were normalized
for the incubation time as well as amount
of protein, because both the incubation
time and the amount oflysosomal protein
were different depending on the substrate:
apo-MT, ZnMT, or CdMT.
In order to determine further the influ-
ence of metal composition on the prote-
olytic breakdown of MT, the degradation
and metal contents ofMT-I and MT-II in
rat liver were examined in vivoduring vari-
ous conditions of induction: neonatal
development, and acute exposure to Zn
(1 mmole/kg, sc), ethanol (109 mmole/kg,
po), or Cd (10 pmole/kg, sc). This was
accomplished by measuring the disappear-
ance of pulse-labeled MT-I and II in liver
(9). Injections of [35S]-cysteine 24 hr after
parturition or 6 hr after inducer pretreat-
ment were employed to radiolabel each iso-
protein. High dosages of nonradiolabeled
cysteine (1 mmole/kg, po) were adminis-
tered 4 hr after [35S]-cysteine and every 24
hr thereafter to minimize reutilization of
radiolabeled amino acid. Iso-MTs were iso-
lated by chromatography and HPLC for
the assessment of the metal content and
specific radiological activity, i.e., dpm of
[35S]-labeled iso-MTs/g liver (9). Zn, Cd,
and Cu content ofMT isoforms were mea-
sured by atomic absorption spectrometry
(AAS). Chemical and radiological concen-
trations of iso-MTs were measured by
HPLC coupled with AAS as described by
Lehman and Klaassen (10), and liquid
scintillation spectrometry, respectively.
Results
Lysosomes probably represent an impor-
tant subcellular compartment that might
be involved in the degradation of MT in
vivo: Previous studies on the degradation of
MT in rat liver indicated that lysosomes
can degrade apo-MT (11,12). However,
apo-MT was also shown to be degraded by
trypsin, which is a neutral cytosolic pro-
tease (11). It was, therefore, our initial goal
to identify the subcellular compartment(s)
that are most likely involved in the in vivo
degradation ofMT. In order to do that, we
investigated the relative abilities of the
whole rat liver homogenate, cytosol, and
lysosome fractions to catabolize apo-MT in
vitro at two different pHs: pH 5.5 (lysoso-
mal pH) and pH 7.2 (cytosolic pH). Apo-
MT was chosen as a substrate because
preliminary studies in our laboratory had
shown that metal-bound forms of MT
were highly resistant to degradation. Table
1 shows that the degradation of apo-MT
reached a maximum (0.78 ± 0.16 nmole
apo-MT degraded/mg protein/min) by
whole rat liver homogenate at pH 5.5. This
was about four times more extensive than
that at pH 7.2 (0.20 ± 0.02 nmole/mg pro-
tein/min). At pH 7.2, cytosolic fraction
could degrade litde apo-MT (0.13 ± 0.03
nmole/mg protein/min), but at pH 5.5, it
could not degrade any apo-MT. Because
the homogenate contained all subcellular
enzymes including lysosomal proteases,
which are most active at acidic pH, these
data suggest the involvement of lysosomes
in degrading apo-MT.
Additional evidence that identifies lyso-
somes as the most likely subcellular site in
MT degradation was obtained when the
relative abilities of lysosomes and
homogenate in degrading apo-MT were
compared. Figure 1 shows that the greatest
degradative activity clearly resides in the
lysosomes having 65 and 390 times greater
proteolytic activity over homogenate and
cytosol, respectively. These observations are
consistent with the previous studies that
indicated lysosomes as the possible intracel-
lular site of MT degradation in vivo
(11-13).
Table 1. Degradation of apo-MT by homogenate and
cystol atpH 5.5and7.2.
Degradation ofapo-MT
Fraction pH nmole/mg protein/min
Homogenate 5.5 0.78±0.16a
Homogenate 7.2 0.20± 0.02a
Cytosol 5.5 NDb
Cytosol 7.2 0.13± 0.03
aEach value represents the mean SE (n=3). bND, no
detectabledegradation.
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Figure 1. Comparison of the degradation of apo-MT by
homogenate and lysosomes at pH 5.5. Separate incuba-
tions of apo-MT with homogenate and lysosomal frac-
tions were carried out at 37°C and pH 5.5 for 2 hr. The
ratioofapo-MTtolysosomal proteinwas80:1 (50 pg apo-
MT: 0.625 pg lysosomal protein), whilethatofapo-MTto
homogenate protein was 1:1 (50 pg apo-MT: 50 pg
homogenate protein).
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Figure 2. Effect of different cathepsin inhibitors on the
degradation ofapo-MT-1. In separate incubations apo-MT
was incubated with the lysosomal fractions in the pres-
ence of 10 pM of any one of the three inhibitor, i.e.,
leupeptin, E-64, andpepstatin.
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Lysosomal Proteases CanEffiiently
Degrade MT In Vtro
Because cathepsins are the principal lysoso-
mal proteases, it seemed probable that the
lysosomal degradation of MT might be
mediated by them. Lysosomes contain
many different cathepsins that mediate
critical catabolic pathway in liver for a wide
array of exogenous and endogenous pro-
teins (14,15). In order to identify the most
important lysosomal enzyme(s) that might
be involved in MT degradation, cathepsin-
specific inhibitors were used (3). Figure 2
illustrates the relative abilities of different
Table 2. Comparison ofthe degradation ofapo-MT,
ZnMTand CdMT.
Form ofMT pH MTdegradation,
pmole/mg protein/min
Apo-MT 5.5 50200 ±43000a
CdMT 5.5 35.0 ± 5.20
ZnMT 5.5 20.5 ±2.80
aEach value representsthe mean SE(n=>9).
Table3. Degradation ofapo-MT,Cd-MT, andZn-MT by
cathepsins B, C, and D.
Cathepsin
Substrate B C D
Apo-MT 12,500 ±1500a 350 ±33 276± 15
Cd-MT 13.0 ± 1.6 ND ND
Zn-MT 2.0 ± 0.30 0.22 ± 0.04 0.63 ± 0.06
aDegradation based on picomoles MTdegraded/U cathep-
sin/min. Values are means ± SEM of one to three time
points from three separate incubations.ND, none
detected.
cathepsin inhibitors to decrease the extent
of apo-MT degradation in vitro.
Leupeptin, which inhibits cathepsin B and
L, inhibited apo-MT degradation the most
(by about 80% of the control). This indi-
cates that cathepsin B and/or L might be
the most important lysosomal protease
involved in the intracellular degradation of
MT. By the same argument, the minimal
effect of pepstatin seems to preclude the
involvement of cathepsin D in MT degra-
dation. The moderate inhibitory effect of
E-64 (about 50% inhibition of degrada-
tion) suggests a role for cathepsin C also,
but this should be viewed with caution in
light ofthe fact that E-64 can also partially
inhibit cathepsin B and L (16).
The relative abilities of cathepsins in
degrading MT were further evaluated by
extending the study to in vitro MT degra-
dation by purified cathepsins (4). The
composition of incubates was similar to
that employed with crude liver extract,
except for their substitution by cathepsin B
(6.0 mU), C (90 mU), or D (75 mU). The
concentrations ofcathepsins used were also
optimized by preliminary studies. The
results of purified cathepsin-mediated in
vitro MT degradation, corroborated nicely
the results obtained from studies using the
inhibitors. Cathepsin B again turned out
to be the most efficient in degrading MT,
followed by cathepsins C and D. The
amount of apo-MT degraded by cathep-
sins B, C, and D were 12,500 ± 1500,
350 ± 33, and 275 ± 15 pmole apo-MT
degraded/U cathepsin/min, respectively.
Therefore, cathepsin B degraded apo-MT
36 and 45 times faster than cathepsins C
and D, respectively. These data further
support our conclusion that cathepsin B, a
cysteinyl acid protease in lysosome, might
be the major player in the in vivo
degradation ofMT.
Comparison ofthe Degradation
ofMetal-free and Metal-bound
Forms ofMT Reveals that
Association of Metals with MT
Protects it from Rapid Proteolysis
It is believed that metals bound to MT
render it resistant to degradation. This
was first shown by Feldman and Cousins
(17) and Feldman et al. (11). Because
there were no quantifications, it was not
possible to compare the degradation of
metal-free and metal-bound forms ofMT
and assess the extent ofprotection against
degradation provided by metals.
When we compared the degradation
ofapo-MT, ZnMT, and CdMT, by either
lysosomal extract or purified cathepsins,
we found that apo-MT degradation was
very rapid, but ZnMT and CdMT were
extremely resistant to degradation. Table
2 shows that degradation of apo-MT by
lysosomal fraction was about 1500 and
2500 times faster than that ofCdMT and
ZnMT, respectively. Similar results were
obtained from studies using purified
cathepsins (Table 3). Degradation ofapo-
MT by purified cathepsin B was about
1000 and 6000 times faster than that of
CdMT and ZnMT, respectively. These
1 2 3 4 5 6
rZnMT rCdMU-T7'
SW T 0 12 24 34 0 12 .24.. 34
TW
-M-4Sl l - l - l l -M
Std MT Ohw 61W l2w 18SW
Figure 3. SOS-PAGE analysis of CdMT collected at dif-
ferent time points following incubation with lysosomal
fraction. Lane 1 on the left contains the molecularweight
markers x 10-3. Lane 2 has control MI-I band containing
20 pg protein. Lanes 3 to 6 have CdMT-1 samples from the
experiment. In each lane 10 pg of MI-I was loaded. The
figure shows that even after 16 hrthere was no apprecia-
ble degradation. Therefore, metals bound to MI protect it
againstproteolysis.
Fgure 4. SDS-PAGE analysis ofZnMT-1 and CdMT-1 following digestion bycathepsin B(350 mUnits). Lane 1 on the left
contains the molecularweight markers x 10-3. Lane 2 has control MT-I band containing 20 pg protein. The figure shows
that ZnMT was more resistant to degradation by cathepsin B than CdMT, and both metals can protect MT from rapid
degradation.
Volume 102, Supplement3, September 1994 143KLAASENETAL.
observations support the existing concept
that metals render MT highly resistant to
degradation.
However, two findings in the present
study are interesting and not reported ear-
lier. First, either ZnMT or CdMT was
found to be more resistant to degradation
than previously reported. Secondly, CdMT
degraded a little faster than ZnMT by both
lysosomal extract and purified cathepsins.
Figure 3 shows an SDS-PAGE analysis of
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Figure 5. Effect of different degrees of metal saturation
on MT degradation. Apo-MT was titrated with various
amounts of Zn to reconstitute MT. The amount of Zn
added to different tubes were equivalent to 0 to 7 mole
Zn/mole apo-MT. All these reconstituted samples were
incubated with lysosomal extract at 370C for various
times, depending onthe MTsaturation level.
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Figure 6. Reconstitution of apo-MT (50 pg) with 0 to 7
molar equivalents of Zn and 6.0 mU of cathepsin B.
Digestions were done as mentioned in Figure 5. Due to
lowvariance, some standard errorbars are notvisible.
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Figure7. DisplacementofZn and Cdfrom MT atdifferent
pHs. Equal aliquots of either ZnMT-11 or CdMT-11 were
placed in dialysis chamber and dialyzed into 41 of sodium
acetate buffer atthe pHs shown, for24 hr.
CdMT that was incubated with lysosomal
extract. After 16 hr, there was no apprecia-
ble degradation. Figure 4 shows an SDS-
PAGE analysis ofboth ZnMT and CdMT,
incubated with cathepsin B. Both ZnMT
and CdMT appear more resistant to degra-
dation than previously thought. Figure 4
and Tables 2 and 3 also clearly depict that
CdMT degraded slightly faster than
ZnMT. This finding was surprising consid-
ering the fact that the affinity ofCd for the
protein moiety of MT is higher than that
ofZn (18,19). However, compared to apo-
MT, the degradation ofZnMT and CdMT
were negligible, and our finding still pro-
vides strong support to the fundamental
concept that metals protect MT against
proteolysis.
Five moles ofmetals/mole MT can dra-
matically decrease degradation, indicating
that displacement of metals from the pro-
tein may be a prerequisite for the initiation
of MT degradation. In order to further
assess metal-dependent stabilization of
MT, Zn was added in increments into the
incubation mixture containing apo-MT.
Figures 5 and 6 are strikingly similar. The
degradation ofapo-MT by either lysosomal
extract (Figure 5) or purified cathepsin B
(Figure 6) decreased in a linear fashion as a
function of increasing amounts of molar
equivalents of Zn added to the reaction
mix. The degradation reduced dramatically
in the presence in the reaction mix of 5 or
more molar equivalents ofZn.
The findings from the foregoing studies
indicate that complete or partial displace-
ment of metals from MT might be an
important prerequisite for degradation to
occur. One possible mechanism for dis-
placement of metals from MT is the low
pH, which exists in the lysosomes. Our
experiment on pH-dependent displace-
ment of Zn and Cd from MT (Figure 7)
reveals that at a pH of4.5, about 70% Zn
was removed and at pH 4.0 nearly all Zn
was displaced from MT. In contrast, at a
pH of3.5, only 30% Cd was removed with
approximately 80% Cd displaced at pH
3.0. Therefore, it requires a higher H+ ion
concentration to displace Cd because of its
higher affinity toward MT (4).
D radation andMetal Composition
ofHepaticIsometaliotioneins In Vwo
The metal compositions and half-lives of
hepatic iso-MTs are presented in Table 4.
The validity of the hypothesis that MT
degradation is regulated by the amount
and/or the species ofmetals associated with
the protein, can be assessed by comparing
the half-lives of the isoproteins with their
respective metal contents. There are two
noteworthy findings that need special men-
tion in this context. First, iso-MTs of
neonates and Zn- or ethanol-treated rats
had similar metal contents, yet the half-
lives of these isoproteins were quite diver-
gent (9-73 hr). Second, MT-II ofneonates
thatwas composed entirelyofZn was more
stable than the iso-MTs that contained Cd,
and therefore MTs of Cd-treated rats.
Curiously, the metal composition hypothe-
sis is not compatible with these results,
since the hypothesis predicts that MTs
with markedly different half-lives will have
qualitative and/or quantitative differences
with respect to their metal contents. An
obvious corollary to the hypothesis is that
metals with higher binding affinity, for
example Cd, would make MT more stable
than those having lower binding affinity,
i.e., Zn. This clearly contradicts with the
data on the half-life ofMT-II in neonates.
Additionally, the reported much shorter
half-life ofZnMT than CdMT (11,17,20)
is also not supported by the present find-
ing. It should be noted in this context that
our findings do not contradict the finding
that metals protect MT against proteolysis.
Conclusion and Future
Prospects
The findings from the present study can be
broadly categorized as follows; those that
corroborate the existing concepts on MT
degradation and those that are different
from the previous reports on certain aspects
ofMT degradation.
Our study provides support for the
"lysosomal theory of degradation," and
identifies lysosomal cathepsins, in particu-
lar cathepsin B, to be an important enzyme
that may be involved in the degradation
Table 4. Meta contentsandhalf-livesofMT-1 and MT-2.a
Metal content,
g atomsmetal/mole MT Half-
Treatment iso-MT Zn Cu Cd Total life, hr
Neonate MT-1 5.5 0.1 NDb 5.6 49
MT-2 5.9 ND ND 5.9 73
Cd-treated MT-1 3.2 0.2 3.2 6.6 58
MT-2 3.4 0.1 2.8 6.3 61
Zn-treated MT-1 6.6 ND ND 6.6 21
MT-2 5.8 0.3 ND 6.1 33
Ethanol- MT-1 6.0 ND ND 6.0 9
treated MT-2 5.8 ND ND 5.8 9
ND; Not detected; the lowest detectable specific metal
content was approximately 0.1 g atom metal/mole MT.
aMetal contents and half-lives of hepatic isometallo-
thioneins were determined as described in "Materials
and Methods." Metal contents represent mean values of
three determinations made upon a single pooled sample
prepared from six adult rats (Cd-, Zn-, or ethanol-treated)
or76 nontreated neonates.
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process. Our study also confirms that met-
als bound to MT protects it from prote-
olytic degradation, and apparently 5 mole
ofmetal/mole MT can dramatically reduce
its degradation. The experiments on metal-
mediated protection strongly suggest that
the release ofmetals from MT is a prereq-
uisite for initiating the degradation.
However, the extent to which metals
protect MT was found to be much greater
in our study than previously suggested.
Feldman et al. (11) reported that it takes
about 1 and 3 hr to degrade about 50%
ZnMT and CdMT, respectively. Our
study showed that even after 16 hr, there
was no appreciable degradation of MT by
lysosomes. This apparent difference might
be explained, at least in part, by the pH
level and the nature ofthe MT used. In the
present study, a pH of5.5 was used. At this
pH, all metals were retained by MT and
therefore, its rapid degradation was inhib-
ited (3,4). In contrast, all previous studies,
including the one by Feldman et al. (11),
employed a pH of5.0 or lower. At this pH,
metals, especially Zn, will be partially dis-
placed from the protein (4), which would
promote rapid initiation of degradation.
This effect of pH also explains why 50%
degradation of CdMT was obtained in
about 3 hr at pH 5.0, although Cd is not
displaced from MT at this pH. The CdMT
used by the previous studies was isolated
following Cd treatment of the animals.
The CdMT formed in vivo is actually a
mixed-metal species of MT, containing
both Zn and Cd (21). The Zn content
of the CdMT can be displaced at pH 5.0
or lower, thereby initiating degradation
ofCdMT.
The slightly faster degradation of
CdMT over ZnMT that was observed in
the present study has not been reported
earlier. It contradicts the fact that CdMT
has a longer in vivo half-life than ZnMT.
In our studies we used fully saturated
ZnMT or CdMT. Different molecular
configuration ofZnMT and CdMT might
offer an explanation, but to this end no
such information exists. It should be
remembered that the degradation of
ZnMT and CdMT was so negligible com-
pared to that ofapo-MT that this apparent
difference in their degradation might be
ignored.
Although recent studies on MT degra-
dation speak strongly in favor ofthe "lyso-
somal theory of degradation,"
involvement ofother subcellular compart-
ments, in particular the cytosolic com-
partment, cannot be ruled out. In fact, in
recent years, an increasing number of
studies have provided strong evidence in
favor of this contention (13,22). The
study by Steinebach and Wolterbeek (22)
has demonstrated that MT in cell exists in
two compartments; the cytosolic compart-
ment (apo-MT) and the lysosomal com-
partment (metal-bound MT), each being
depleted and replenished at different rates.
In our laboratory, the current research
interest is to identify the cytsosolic enzy-
matic component(s) that may be involved
in the degradation of MT, in particular
the cytosolic pool ofMT.
Apart from the different subcellular
compartments, many other factors might
potentially contribute to the intracellular
turnover of MT. For example, it was
demonstrated that MT is localized mainly
in the nucleus during development
(23,24). It can be argued that, because
MT is localized mainly in the nucleus dur-
ing development, its limited availability to
the degradation machinery (cytosol and/or
lysosomes) might be a factor that can regu-
late its accumulation in the cell during
development. This might account for the
reportedly high level ofhepatic MT in the
livers of neonatal rats (25). Another
important but unexplored area in MT
degradation research is examining the pos-
sibility of involvement of the ubiquitin
system in MT turnover. Finally, various
post-transcriptional events, including
translational control, might also play
important role. Clough et al. (26) reported
that human fetal liver tissue contains a
third charge-separable MT isoform.
Soumillion et al. (27) termed it MT-O,
and demonstrated the presence of MT-O
mRNA in adult liver, despite the complete
absence ofthis isoform at the protein level.
Thus, the intracellular turnover ofMT
and its regulation appear to be much more
complex than previously contemplated.
The current status of knowledge suggests
the involvement of lysosomal and
extralysosomal (possibly cytosolic) com-
partments in the intracellular turnover of
MT. However, it is not known yet ifthese
compartments cooperate with each other
in a concerted fashion to degrade the total
cellular MT pool, or if they act indepen-
dently of each other to degrade separate
compartmentalized MT pools. Therefore,
the existing knowledge about MT degra-
dation is fragmentory, and more work is
needed in this area in order to gain a com-
plete insight of the steps and processes
involved. For this purpose, use of special
cell lines/transgenic models that either
overexpress, or are deficient in specific
components of the intracellular degrada-
tion machinery, might prove to be
extremely helpful.
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